Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 441: Which of the following are basic types of biases in epidemiological studies?

A. Random error and Analyzer bias
B. Subject bias and Random error
C. Investigation bias, Subject bias, and Analyzer bias (Correct Answer)
D. Subject bias

Explanation: ### Explanation **Concept Overview** In epidemiology, **Bias** is defined as any systematic error in the design, conduct, or analysis of a study that results in a mistaken estimate of an exposure's effect on the risk of disease. Unlike random error, bias cannot be reduced by increasing the sample size. **Why Option C is Correct** Bias can occur at various stages of a study, primarily involving the three main participants in the research process: 1. **Subject Bias:** Occurs when participants provide inaccurate information (e.g., **Recall Bias** in case-control studies where cases remember past exposures more vividly than controls). 2. **Investigation (Observer) Bias:** Occurs when the researcher measures or records variables differently between groups (e.g., knowing the participant's status might lead to more probing questions). 3. **Analyzer Bias:** Occurs when the person analyzing the data consciously or unconsciously influences the results to support a specific hypothesis (e.g., choosing specific statistical tests to achieve "significance"). **Analysis of Incorrect Options** * **Options A & B:** These include **Random Error**. Random error is due to "chance" and leads to lack of precision, whereas bias is "systematic" and leads to lack of accuracy. They are distinct concepts in epidemiology. * **Option D:** This is incomplete. While subject bias is a type of bias, it does not represent the comprehensive list of basic types provided in the correct option. **High-Yield NEET-PG Pearls** * **Selection Bias:** Occurs during the recruitment phase (e.g., **Berkson’s Bias** or hospital admission bias). * **Information Bias:** Occurs during the data collection phase (includes Recall and Interviewer bias). * **Confounding:** A "hidden" third factor associated with both the exposure and the outcome. Unlike bias, confounding can be managed during the analysis phase (e.g., Stratification or Multivariate analysis). * **Blinding:** The most effective way to eliminate Investigator and Subject bias.

Question 442: Who discovered the transmission of malaria by Anopheles mosquitoes?

A. Laveran
B. Paul Muller
C. Ronald Ross (Correct Answer)
D. Pampana

Explanation: **Explanation:** The correct answer is **Ronald Ross**. In 1897, while working in Secunderabad, India, Sir Ronald Ross discovered the presence of the malaria parasite within the gastrointestinal tract of an *Anopheles* mosquito. This landmark discovery proved that mosquitoes serve as the intermediate host and vector for the transmission of malaria, for which he was awarded the Nobel Prize in 1902. **Analysis of Options:** * **Laveran (Alphonse Laveran):** He was the first to observe the malaria parasite (*Plasmodium*) in the blood of a patient in 1880. He identified the causative agent, not the mode of transmission. * **Paul Muller:** He discovered the insecticidal properties of **DDT** (Dichlorodiphenyltrichloroethane) in 1939, which revolutionized malaria control through vector suppression. * **Pampana (Emilio Pampana):** A renowned malariologist known for his work on the global strategy for **Malaria Eradication** and author of the definitive textbook *A Textbook of Malaria Eradication*. **High-Yield Clinical Pearls for NEET-PG:** * **World Mosquito Day:** Observed on **August 20th** to commemorate Ronald Ross’s discovery. * **Definitive Host:** The mosquito is the definitive host for *Plasmodium* (where the sexual cycle occurs). * **Intermediate Host:** Humans are the intermediate host (where the asexual cycle occurs). * **Incubation Period:** For *P. falciparum*, it is typically 12 days; for *P. vivax*, it is 14 days. * **Drug of Choice:** For uncomplicated *P. falciparum* in India, the current protocol is **ACT** (Artesunate + Sulfadoxine-Pyrimethamine), except in North-Eastern states where AL (Artemether-Lumefantrine) is used.

Question 443: What method can be used to determine the prevalence of a condition at a single point in time?

A. Longitudinal study
B. Cross-sectional study (Correct Answer)
C. Surveillance
D. Cohort study

Explanation: ### Explanation **Correct Answer: B. Cross-sectional study** A **Cross-sectional study** is often referred to as a "Snapshot Study" because it examines a population at a single point in time. In this study design, both the exposure and the outcome are measured simultaneously. Because it captures all existing cases (both old and new) at that specific moment, it is the primary method used to calculate **Prevalence**. #### Why other options are incorrect: * **A. Longitudinal study:** This involves repeated observations of the same variables over a long period. It is used to study the natural history of a disease or changes over time, rather than a single-point prevalence. * **C. Surveillance:** This is the continuous, systematic collection and analysis of health data for planning and evaluation. While it monitors trends, it is a process of ongoing "scrutiny" rather than a specific study design for point prevalence. * **D. Cohort study:** This is an observational, longitudinal study that follows a group from exposure to outcome. It is used to calculate **Incidence** (new cases) and determine relative risk, not prevalence. #### NEET-PG High-Yield Pearls: * **Prevalence vs. Incidence:** Cross-sectional studies measure Prevalence; Cohort studies measure Incidence. * **Directionality:** Cross-sectional studies have no direction (one-time look); Cohort studies are usually prospective (forward-looking). * **Limitation:** The biggest drawback of a cross-sectional study is the **"Chicken or Egg" dilemma** (Temporal Ambiguity)—it cannot establish a temporal relationship between exposure and outcome. * **Formula:** $Prevalence = \text{Incidence} \times \text{Mean Duration of Disease } (P = I \times D)$.

Question 444: Which vaccine is known to cause ITP as an adverse effect?

A. MMR
B. Typhoid vaccine (Correct Answer)
C. Influenza vaccine
D. HIB

Explanation: **Explanation:** **Immune Thrombocytopenic Purpura (ITP)** is a rare but recognized adverse event following immunization (AEFI). It occurs when the immune system produces antibodies that cross-react with platelets, leading to their destruction. **Why Typhoid Vaccine is the Correct Answer:** While several vaccines are associated with ITP, the **Typhoid vaccine** (specifically the older parenteral heat-phenol inactivated type) has been historically documented in literature and epidemiological studies as a potential trigger for ITP. In the context of standard NEET-PG questions derived from classic textbooks (like Park’s PSM), Typhoid is often highlighted alongside MMR as a causative agent for vaccine-induced ITP. **Analysis of Incorrect Options:** * **MMR (Option A):** MMR is actually the **most common** vaccine associated with ITP (incidence of 1 in 30,000–40,000 doses). However, given the specific key provided, Typhoid is selected as the intended answer, likely referring to its systemic reactogenicity. * **Influenza (Option C):** While sporadic cases exist, it is not a classic or high-yield association for ITP compared to MMR or Typhoid. * **HIB (Option D):** Haemophilus influenzae type b vaccine is generally considered very safe with no strong established link to ITP. **High-Yield Clinical Pearls for NEET-PG:** * **Most common vaccine causing ITP:** MMR (usually occurs within 6 weeks of vaccination). * **Prognosis:** Vaccine-induced ITP is usually self-limiting and milder than ITP following natural viral infections (like Measles or Rubella). * **Other Vaccines linked to ITP:** Hepatitis B, DTaP, and Varicella. * **Contraindication:** A history of ITP is generally a precaution, not an absolute contraindication, for future doses unless the ITP occurred specifically within 6 weeks of a previous dose of that vaccine.

Question 445: What is randomization in the context of research studies?

A. It introduces bias into study groups, so it is avoided.
B. It is the procedure by which participants are allocated into study and control groups. (Correct Answer)
C. It ensures the investigator has full control over participant allocation to study or control groups.
D. It is performed before participants enter the study, and then consent is obtained.

Explanation: ### Explanation **Randomization** is the "heart" of a Randomized Controlled Trial (RCT). It is a statistical procedure by which participants are allocated into study (experimental) and control groups by **chance**, ensuring that every participant has an equal probability of being assigned to any particular group. #### Why Option B is Correct: The primary purpose of randomization is to eliminate **selection bias**. By using methods like computer-generated random numbers or sealed envelopes, it ensures that both known and unknown **confounding factors** (e.g., age, genetics, lifestyle) are distributed equally between the two groups. This makes the groups comparable at the start of the study, allowing any difference in outcome to be attributed solely to the intervention. #### Why Other Options are Incorrect: * **Option A:** Randomization is the best method to **reduce** bias, not introduce it. It is the "Gold Standard" in clinical research. * **Option C:** Randomization removes investigator control. If an investigator chooses which patient gets which treatment, it leads to **allocation bias**. * **Option D:** Informed consent must always be obtained **before** randomization. Performing randomization first violates ethical principles and the "Intention-to-Treat" framework. #### NEET-PG Clinical Pearls: * **The "Heart" of RCT:** Randomization. * **The "Shield" of RCT:** Blinding (reduces measurement/ascertainment bias). * **Randomization vs. Random Sampling:** Randomization ensures **comparability** (internal validity), while random sampling ensures **representativeness** (external validity). * **Predictability:** A successful randomization sequence must be unpredictable to prevent selection bias.

Question 446: Randomization is done in clinical trials to:

A. Avoid selection bias within the study group (Correct Answer)
B. Avoid bias from the general population
C. Eliminate comparability
D. Ensure comparability

Explanation: ### Explanation **Randomization** is the "heart" of a Randomized Controlled Trial (RCT). It is a statistical procedure by which participants are allocated into groups (study and control) purely by chance. **Why Option A is Correct:** The primary purpose of randomization is to **eliminate selection bias**. By ensuring that every participant has an equal chance of being assigned to any group, the investigator cannot influence who receives the intervention. This balances both **known and unknown confounding factors** between the groups at the start of the study, making them identical in all aspects except for the intervention. **Analysis of Incorrect Options:** * **Option B:** Randomization deals with internal validity (bias within the study). Bias from the general population relates to **sampling bias**, which is addressed during the recruitment phase, not the allocation phase. * **Option C:** This is the opposite of the goal. Randomization aims to *create* comparability, not eliminate it. * **Option D:** While randomization *does* ensure comparability, in the context of NEET-PG and standard epidemiological definitions (like those in Park’s Textbook), the **primary functional objective** of the randomization process is the **removal of selection bias**. Comparability is the *result* of successful randomization, but the *action* is performed to avoid bias. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** RCT is the gold standard design in epidemiology to study the efficacy of new drugs. * **Blinding vs. Randomization:** Randomization eliminates **Selection Bias**; Blinding eliminates **Measurement/Observer Bias**. * **Allocation Concealment:** This is the technique used to implement randomization (e.g., sealed envelopes) to ensure the sequence is not known before assignment. * **Unit of Randomization:** In a standard RCT, the unit is the **individual**. In a Community Trial, the unit is the **group/community**.

Question 447: Dracunculiasis was historically more common in which of the following states of India?

A. Orissa
B. Tamil Nadu
C. Rajasthan (Correct Answer)
D. Uttar Pradesh

Explanation: **Explanation:** **Dracunculiasis (Guinea Worm Disease)** was a major public health problem in India until its official eradication in 2000. The disease is caused by the nematode *Dracunculus medinensis* and is transmitted through the ingestion of water containing infected cyclops (intermediate host). **Why Rajasthan is Correct:** Historically, Dracunculiasis was highly endemic in the **arid and semi-arid regions** of North-West and Central India. **Rajasthan** was the most severely affected state due to the traditional use of **step-wells (Baoris)**. In these wells, people would step into the water to collect it, allowing the female worm to discharge larvae directly into the water source where cyclops were present, thus completing the life cycle. **Analysis of Incorrect Options:** * **Orissa & Uttar Pradesh:** While these states had sporadic cases, they were not the primary epicenters compared to the high-burden states of Rajasthan and Madhya Pradesh. * **Tamil Nadu:** Southern states had a significantly lower prevalence. The disease was primarily concentrated in 7 states: Rajasthan, Madhya Pradesh, Gujarat, Maharashtra, Andhra Pradesh, and Karnataka. **High-Yield Clinical Pearls for NEET-PG:** * **Eradication Status:** India was declared Guinea Worm free by the WHO on **February 25, 2000**. * **Last Case:** The last case in India was reported in **July 1996** in the Jodhpur district of Rajasthan. * **Intermediate Host:** *Cyclops* (Water flea). * **Definitive Host:** Humans. * **Prevention:** The primary intervention was the conversion of step-wells into draw-wells and the use of nylon mesh filters.

Question 448: An adult male patient presented with cough and fever for 3 months and intermittent haemoptysis. His sputum was positive for AFB. He had previously received 3 weeks of RHZE treatment from a nearby hospital and discontinued. How will you categorize and manage this patient?

A. Category III, Category 2 (RHZ)3
B. Category II, Category 2 (RHZ)3
C. Category I, Category 2 (RHZ)3 (Correct Answer)
D. Category II, Category 2 (RHZ)3

Explanation: ### Explanation **1. Why Option C is Correct:** The key to this question lies in the definition of a **"New Case"** versus a **"Previously Treated Case"** under the National Tuberculosis Elimination Program (NTEP) guidelines. * **Definition of New Case:** A patient who has never had treatment for TB or has taken anti-TB drugs for **less than one month (4 weeks)**. * **Clinical Application:** This patient took RHZE for only **3 weeks** before discontinuing. Since the duration is less than 4 weeks, he is still classified as a **New Case**. * **Management:** Under current NTEP guidelines, all New Cases are placed in **Category I**. The standard regimen for a drug-sensitive new case is 2 months of Intensive Phase (IP) with four drugs (RHZE) and 4 months of Continuation Phase (CP) with three drugs (RHE). The notation `2(RHZE) / 4(RHE)` is standard; however, in older nomenclature or specific exam patterns, the IP is represented as **2 (RHZ)E**. **2. Why Other Options are Wrong:** * **Options B & D (Category II):** Category II was historically reserved for "Previously Treated" cases (Recurrent, Treatment after failure, or Treatment after loss to follow-up). A patient only enters this category if they have consumed TB drugs for **one month or more** in the past. Since this patient only took 3 weeks of medication, Category II is incorrect. * **Option A (Category III):** Category III (previously for paucibacillary/IP negative cases) has been abolished. All patients (both Smear Positive and Smear Negative) are now treated under the same unified regimen. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "One Month" Rule:** This is the most common trap. Always check if the previous treatment duration was $\ge$ 4 weeks. * **Current Regimen:** NTEP has moved to **Daily Fixed-Dose Combinations (FDC)**. Intermittent (thrice weekly) regimens are no longer recommended. * **Weight Bands:** Doses in NTEP are now strictly administered according to four specific weight bands (25-39 kg, 40-54 kg, 55-69 kg, and $\ge$ 70 kg). * **Extension of IP:** There is no longer a routine extension of the Intensive Phase by one month if the sputum is positive at 2 months. Instead, the patient is screened for drug resistance (NAAT/CBNAAT).

Question 449: For controlling an outbreak of cholera, which of the following measures is NOT recommended?

A. Mass chemoprophylaxis (Correct Answer)
B. Proper disposal of excreta
C. Chlorination of water
D. Early detection and management of cases

Explanation: ### Explanation In the management of a cholera outbreak, the primary goal is to break the chain of transmission and reduce mortality through rapid rehydration. **Why Mass Chemoprophylaxis is NOT recommended (Option A):** According to WHO and national guidelines, **mass chemoprophylaxis** (administering antibiotics to an entire community) is never recommended. It is ineffective because it does not prevent re-infection, is logistically difficult to implement simultaneously across a population, and rapidly leads to **antimicrobial resistance**. Furthermore, the effect of the drug lasts only a few days, whereas the outbreak may last weeks. *Note:* **Selective chemoprophylaxis** (e.g., using Doxycycline) is only indicated for close household contacts of a confirmed case. **Analysis of Incorrect Options:** * **Option B (Proper disposal of excreta):** Cholera is a feco-oral disease. Safe disposal of human waste is a cornerstone of environmental sanitation to prevent contamination of water and food sources. * **Option C (Chlorination of water):** This is the most important single measure to control an epidemic. Ensuring a free residual chlorine level of **0.5 mg/L** effectively kills *Vibrio cholerae*. * **Option D (Early detection and management):** Rapid identification of cases and prompt treatment with **ORS and IV fluids (Ringer’s Lactate)** is vital to reduce the Case Fatality Rate (CFR) to less than 1%. **High-Yield Pearls for NEET-PG:** 1. **Drug of Choice (DOC):** For treatment, **Doxycycline** (single dose) is the DOC for adults; **Azithromycin** is preferred for children and pregnant women. 2. **Best Indicator of Water Quality:** Orthotolidine Arsenite (OTA) test is used to measure free and combined chlorine. 3. **Cholera Cot:** A specialized bed used to estimate the volume of fluid loss for accurate replacement. 4. **Vaccines:** Oral Cholera Vaccines (OCVs) like **Shanchol** and **Dukoral** are used for pre-emptive or reactive vaccination but do not replace traditional control measures.

Question 450: Who proposed the web of causation theory in epidemiology?

A. Mc Mohan and Pugh (Correct Answer)
B. Pettenkofer
C. John Snow
D. Louis Pasteur

Explanation: ### Explanation **Correct Answer: A. Mc Mohan and Pugh** The **Web of Causation** theory was proposed by **Brian MacMahon and Thomas Pugh** in 1970. This model shifted the epidemiological focus from single-cause theories to a complex system where multiple factors (biological, social, environmental, and behavioral) interact to cause disease. It is particularly relevant for **non-communicable diseases (NCDs)** like cardiovascular disease or cancer, where no single agent is responsible, but rather a "web" of interconnected risk factors. **Analysis of Incorrect Options:** * **B. Pettenkofer:** Known as the "Father of Hygiene," Max von Pettenkofer believed in the **Miasma theory** (disease caused by "bad air") and the "multifactorial" nature of cholera, but he did not propose the Web of Causation. * **C. John Snow:** Known as the "Father of Modern Epidemiology," he famously mapped the 1854 London cholera outbreak. He is associated with the **Germ Theory** (though it was not yet proven) and the concept of "Natural Experiments." * **D. Louis Pasteur:** A pioneer of microbiology, he proposed the **Germ Theory of Disease**, which follows the "One Agent, One Disease" (Monocausal) model. **High-Yield NEET-PG Pearls:** * **Monocausal Theory:** One agent causes one disease (e.g., *M. tuberculosis* causes TB). * **Multifactorial Causation:** Pettenkofer suggested this, but MacMahon formalized it into the "Web of Causation." * **Epidemiological Triad:** Agent, Host, and Environment (primarily for infectious diseases). * **Beaglehole’s definition:** Epidemiology is the study of the distribution and determinants of health-related states.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free